BG101582A - Пиперазинови производни, съдържащите ги лекарствени форми, приложението им и метод за тяхното получаване - Google Patents
Пиперазинови производни, съдържащите ги лекарствени форми, приложението им и метод за тяхното получаванеInfo
- Publication number
- BG101582A BG101582A BG101582A BG10158297A BG101582A BG 101582 A BG101582 A BG 101582A BG 101582 A BG101582 A BG 101582A BG 10158297 A BG10158297 A BG 10158297A BG 101582 A BG101582 A BG 101582A
- Authority
- BG
- Bulgaria
- Prior art keywords
- piperazine derivatives
- receiving
- application
- containing medicinal
- medicinal forms
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000004885 piperazines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Пиперазиновите производни имат обща формула, в която Rа, Y1 до Y3 и E имат значенията, посочени в описанието. Изобретението се отнася още до техните тавтомери, стереоизомери, включително и смесите им, до техните соли, по-специално физиологично съвместимите им соли с неорганични или органични киселини или бази, имащи ценни фармакологични свойства, преди всичко действие, инхибиращо на агрегацията, до лекарствените форми, съдържащи тези съединения и до тяхното приложение и метод за получаването им.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19944446301 DE4446301A1 (de) | 1994-12-23 | 1994-12-23 | Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE19526678A DE19526678A1 (de) | 1994-12-23 | 1995-07-21 | Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE1995133639 DE19533639A1 (de) | 1994-12-23 | 1995-09-12 | Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| PCT/EP1995/005031 WO1996020173A1 (de) | 1994-12-23 | 1995-12-19 | Piperazinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101582A true BG101582A (bg) | 1998-01-30 |
Family
ID=27207101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101582A BG101582A (bg) | 1994-12-23 | 1997-06-06 | Пиперазинови производни, съдържащите ги лекарствени форми, приложението им и метод за тяхното получаване |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5922717A (bg) |
| EP (1) | EP0799202A1 (bg) |
| JP (1) | JPH10511374A (bg) |
| CN (1) | CN1183770A (bg) |
| AR (1) | AR002950A1 (bg) |
| AU (1) | AU4432496A (bg) |
| BG (1) | BG101582A (bg) |
| BR (1) | BR9510360A (bg) |
| CA (1) | CA2207618A1 (bg) |
| CZ (1) | CZ189197A3 (bg) |
| EE (1) | EE9700141A (bg) |
| FI (1) | FI972646L (bg) |
| HR (1) | HRP950609A2 (bg) |
| IL (1) | IL116517A0 (bg) |
| MX (1) | MX9704745A (bg) |
| NO (1) | NO972881L (bg) |
| PL (1) | PL321003A1 (bg) |
| SK (1) | SK79797A3 (bg) |
| TR (1) | TR199501634A2 (bg) |
| WO (1) | WO1996020173A1 (bg) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996019223A1 (en) * | 1994-12-22 | 1996-06-27 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| EP0858457A1 (de) * | 1995-10-20 | 1998-08-19 | Dr. Karl Thomae GmbH | 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung |
| UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
| US6472397B1 (en) | 1998-04-09 | 2002-10-29 | Meiji Seika Kaisha, Ltd. | Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof |
| CA2352957A1 (en) * | 1999-09-29 | 2001-04-05 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamides for the treatment of integrin-mediated disorders |
| EP1533310A1 (en) * | 1999-09-29 | 2005-05-25 | Ortho-McNeil Pharmaceutical, Inc. | Isonipecotamides for the treatment of integrin-mediated disorders |
| USRE39921E1 (en) | 1999-10-07 | 2007-11-13 | Smithkline Beecham Corporation | Chemical compounds |
| GB9923748D0 (en) | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
| GB0025354D0 (en) | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
| DE60208186T2 (de) * | 2001-04-09 | 2006-08-24 | Ortho-Mcneil Pharmaceutical Research Inc. | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrin-vermittelten erkrankungen |
| EP1427418B1 (en) | 2001-08-24 | 2009-11-11 | Yale University | Piperazinone compounds as anti-tumor and anti-cancer agents |
| FR2829766A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives d'oxamates comportant un heterocycle azote diversement substitue |
| GB0203020D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| GB0203022D0 (en) | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
| WO2003066589A1 (en) | 2002-02-08 | 2003-08-14 | Glaxo Group Limited | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases |
| JP5299810B2 (ja) * | 2004-02-27 | 2013-09-25 | アムジエン・インコーポレーテツド | 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法 |
| US7851474B2 (en) * | 2005-08-02 | 2010-12-14 | Neurogen Corporation | Dipiperazinyl ketones and related analogues |
| AU2006309050B2 (en) | 2005-10-28 | 2012-08-16 | Merck Sharp & Dohme Corp. | Piperidine glycine transporter inhibitors |
| NZ573129A (en) | 2006-06-28 | 2011-06-30 | Amgen Inc | Piperazine acetic acid glycine transporter-1 inhibitors |
| WO2008013622A2 (en) * | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| US9090604B2 (en) | 2006-07-27 | 2015-07-28 | E I Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| EP2280008B1 (en) | 2007-01-16 | 2013-05-29 | Purdue Pharma L.P. | Heterocyclic-substituted piperidines as orl-1 ligands |
| TW201322983A (zh) * | 2007-08-31 | 2013-06-16 | Purdue Pharma Lp | 經取代之喹□啉型哌啶化合物及其用途 |
| WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| EP2723718A1 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| US8710043B2 (en) | 2011-06-24 | 2014-04-29 | Amgen Inc. | TRPM8 antagonists and their use in treatments |
| CN104334541A (zh) * | 2012-02-16 | 2015-02-04 | 纽约大学 | 使用低聚氧代哌嗪非肽螺旋模拟物对低氧诱导基因表达的控制 |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| EP2945631A4 (en) | 2013-01-19 | 2016-06-29 | Univ New York | OLIGOOXOPIPERAZINE FOR THE REACTIVATION OF P53 |
| EP3145921A4 (en) | 2014-05-21 | 2017-11-08 | New York University | Oxopiperazine helix mimetics for control of hypoxia-inducible gene expression |
| CN118434717A (zh) * | 2021-12-20 | 2024-08-02 | 西格马-奥尔德里奇有限责任公司 | 化学接头 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2926472A1 (de) * | 1979-06-30 | 1981-01-15 | Thomae Gmbh Dr K | Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel |
| ZA825719B (en) * | 1981-09-03 | 1983-06-29 | Recordati Chem Pharm | Alkanoylanilides |
| PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
| US4895846A (en) * | 1984-04-11 | 1990-01-23 | Bristol-Myers Company | Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties |
| US4778796A (en) * | 1985-07-19 | 1988-10-18 | Dainippon Pharmaceutical Co., Ltd. | ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same |
| DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE4213919A1 (de) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4332168A1 (de) * | 1993-02-22 | 1995-03-23 | Thomae Gmbh Dr K | Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| EP0690847A1 (en) * | 1993-03-29 | 1996-01-10 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
| EP0691959B1 (en) * | 1993-03-29 | 1998-07-22 | Zeneca Limited | Heterocyclic derivatives as platelet aggregation inhibitors |
| DE4324580A1 (de) * | 1993-07-22 | 1995-01-26 | Thomae Gmbh Dr K | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| DE4326344A1 (de) * | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| TW397831B (en) * | 1994-07-15 | 2000-07-11 | Meiji Seika Kaisha | The anti-platelet-agglutination hexahydrogenated pyridine and its derivatives |
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
-
1995
- 1995-12-19 AU AU44324/96A patent/AU4432496A/en not_active Abandoned
- 1995-12-19 MX MX9704745A patent/MX9704745A/es unknown
- 1995-12-19 JP JP8520188A patent/JPH10511374A/ja active Pending
- 1995-12-19 CZ CZ971891A patent/CZ189197A3/cs unknown
- 1995-12-19 EP EP95943168A patent/EP0799202A1/de not_active Withdrawn
- 1995-12-19 FI FI972646A patent/FI972646L/fi not_active Application Discontinuation
- 1995-12-19 CA CA002207618A patent/CA2207618A1/en not_active Abandoned
- 1995-12-19 CN CN95196854A patent/CN1183770A/zh active Pending
- 1995-12-19 BR BR9510360A patent/BR9510360A/pt not_active Application Discontinuation
- 1995-12-19 WO PCT/EP1995/005031 patent/WO1996020173A1/de not_active Ceased
- 1995-12-19 EE EE9700141A patent/EE9700141A/xx unknown
- 1995-12-19 SK SK797-97A patent/SK79797A3/sk unknown
- 1995-12-19 PL PL95321003A patent/PL321003A1/xx unknown
- 1995-12-20 HR HR19533639.9A patent/HRP950609A2/hr not_active Application Discontinuation
- 1995-12-21 TR TR95/01634A patent/TR199501634A2/xx unknown
- 1995-12-21 US US08/576,528 patent/US5922717A/en not_active Expired - Fee Related
- 1995-12-22 IL IL11651795A patent/IL116517A0/xx unknown
- 1995-12-22 AR ARP950100727A patent/AR002950A1/es unknown
-
1997
- 1997-06-06 BG BG101582A patent/BG101582A/bg unknown
- 1997-06-20 NO NO972881A patent/NO972881L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ189197A3 (cs) | 1998-01-14 |
| CN1183770A (zh) | 1998-06-03 |
| FI972646A7 (fi) | 1997-08-19 |
| NO972881D0 (no) | 1997-06-20 |
| CA2207618A1 (en) | 1996-07-04 |
| AU4432496A (en) | 1996-07-19 |
| FI972646A0 (fi) | 1997-06-19 |
| US5922717A (en) | 1999-07-13 |
| TR199501634A2 (tr) | 1996-07-21 |
| EE9700141A (et) | 1997-12-15 |
| AR002950A1 (es) | 1998-05-27 |
| EP0799202A1 (de) | 1997-10-08 |
| JPH10511374A (ja) | 1998-11-04 |
| MX9704745A (es) | 1997-10-31 |
| FI972646L (fi) | 1997-08-19 |
| NO972881L (no) | 1997-06-20 |
| SK79797A3 (en) | 1997-11-05 |
| IL116517A0 (en) | 1996-03-31 |
| HRP950609A2 (en) | 1997-10-31 |
| WO1996020173A1 (de) | 1996-07-04 |
| PL321003A1 (en) | 1997-11-24 |
| BR9510360A (pt) | 1997-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101582A (bg) | Пиперазинови производни, съдържащите ги лекарствени форми, приложението им и метод за тяхното получаване | |
| NO920957L (no) | Cykliske urinstoffderivater og legemidler inneholdende disse forbindelser | |
| NO933248L (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| BG103945A (bg) | Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а | |
| NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| NO923466L (no) | Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser | |
| IL102847A0 (en) | Cyclic imino derivatives,their preparation and pharmaceutical compositions containing them | |
| MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
| NO922940L (no) | Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem | |
| BR9807843A (pt) | Heterociclos bicìclicos dissubstituìdos, sua preparação e seu emprego como medicamentos | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| EA200300671A1 (ru) | Производные хиназолина, содержащие эти соединения лекарственные средства, их применение и способ их получения | |
| BG100946A (bg) | Нови аминокиселинни производни, метод за получаването им и фармацевтични състави съдържащи ги | |
| BR0112986A (pt) | Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano | |
| EA200200651A1 (ru) | Замещенные пиперидины, содержащие эти соединения лекарственные средства и способ их получения | |
| BR0116605A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono | |
| MX9700020A (es) | Derivados ciclicos de una urea, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| AR006569A1 (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion | |
| NO932120L (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| YU30902A (sh) | Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju | |
| NO931527L (no) | Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling | |
| FR2804958B1 (fr) | Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant | |
| YU31995A (sh) | Benzotiofeni glikopiranozida, postupak za njihovo dobijanje i njihova farmaceutska formulacija | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| EE9700292A (et) | Asendatud fenüülamidiinid, neid ühendeid sisaldavad ravimid ja meetod nende valmistamiseks |